Indication: Bacterial Infection
An Open label, Dose-finding, Pharmacokinetics, Safety, and Tolerability Study of Oritavancin Single Dose Infusion in Pediatric Subjects Less Than 18 Years of Age with Suspected or Confirmed Bacterial Infections
Sub-indication: Bacterial Infection
Study Type: Drug Study
Principal Investigator: Janice Sullivan, M.D.Norton Children's Critical Care, affiliated with the UofL School of Medicine
Sponsor: Sponsor: Melinta Therapeutics, Inc.
Email for more information: NCRI-ID@NortonHealthcare.org